Jan Mitchell

发表

The MacDQoL individualized measure of the impact of macular degeneration on quality of life: reliability and responsiveness.

Martin Rubinstein, Stephen J Anderson, Clare Bradley, 2008, American journal of ophthalmology.

Health and Quality of Life Outcomes Quality of Life in Age-related Macular Degeneration: a Review of the Literature

Clare Bradley, C. Bradley, Jan Mitchell, 2022 .

Peer support for people newly diagnosed with macular degeneration: A pilot study

C. Bradley, Jan Mitchell, P. Bradley, 2005 .

+Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of life

S. Anderson, J. Wolffsohn, M. Rubinstein, 2005, Health and quality of life outcomes.

Measuring Quality of Life in Macular Degeneration

C. Bradley, Jan Mitchell, 2010 .

14 The MacDQOL Individualized Measure of the Impact of Macular Disease on Quality of Life

C. Bradley, Jan Mitchell, A. Woodcock, 2010 .

Title: Design of an individualised measure of the impact of macular disease

C. Bradley, Jan Mitchell, 2004 .

Investigating the burden of wet macular degeneration.

Jan Mitchell, 2007, Archives of ophthalmology.

Valvular and Congenital Heart Disease N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long- term follow-up

P. McLaughlin, V. Džavík, P. Daly, 2004 .

Pain, distress, and adult-child interaction during venipuncture in pediatric oncology: an examination of three types of venous access.

C. V. von Baeyer, Lara J. Spagrud, Christopher Mpofu, 2008, Journal of pain and symptom management.

Maternal and Newborn Hospital Outcomes of Perinatal SARS-CoV-2 Infection: A National Registry.

Eileen M. Walsh, Melissa A. Babilonia-Rosa, Kathryn M. Kauffman, 2023, Pediatrics.

Design and development of the MacTSQ measure of satisfaction with treatment for macular conditions used within the IVAN trial

C. Bradley, Jan Mitchell, 2018, Journal of Patient-Reported Outcomes.

Psychometric evaluation of the 12-item Well-being Questionnaire for use with people with macular disease

C. Bradley, Jan Mitchell, 2004, Quality of Life Research.

N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up.

P. McLaughlin, V. Džavík, P. Daly, 2004, American heart journal.

Design of an Individualised Measure of the Impact of Macular Disease on Quality of Life (the MacDQoL)

Clare Bradley, C. Bradley, Jan Mitchell, 2004, Quality of Life Research.

Quality of life and health economic assessments of age-related macular degeneration.

G. Berdeaux, C. Bradley, Jan Mitchell, 2007, Survey of ophthalmology.

Measuring quality of life in macular disease: What use are utilities?

C. Bradley, Jan Mitchell, 2005 .

14 The MacDQOL Individualized Measure of the Impact of Macular Disease on Quality of Life

Jan Mitchell, Clare Bradley, Alison Woodcock, 2010 .